1 citations
,
September 2021 in “Journal of Cosmetic Dermatology” This study found that the ACE gene I/D polymorphism may serve as a genetic susceptibility indicator for androgenetic alopecia in an Egyptian patient group.
2 citations
,
January 2014 in “Medical Principles and Practice” This study found that patients with rosacea had significantly more radiological evidence of chronic rhinosinusitis, and erythematotelangiectatic severity was associated with CRS.
August 2021 in “Journal of emerging technologies and innovative research” This review examines the efficacy of platelet-rich plasma for treating hair loss, highlighting the lack of standardized protocols for PRP preparation and delivery and reporting no new clinical results.
December 2021 in “International Journal of Research in Dermatology” This study found that female pattern hair loss in Saudi women was associated with lower hematological parameters and serum ferritin levels, suggesting iron deficiency may contribute to the disease.
2 citations
,
September 2023 in “Health science reports” This meta-analysis found a strong association between metabolic syndrome and certain skin diseases, including psoriasis, hidradenitis suppurativa, androgenetic alopecia, and lichen planus, suggesting increased risk compared to the general population.
3 citations
,
January 2019 in “The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology” Korean medicine treatments for alopecia often show partial improvement but need more research for standardized guidelines.
September 2024 in “Alcohol and Alcoholism” This study suggests that alcohol consumption may have a less significant impact on androgenetic alopecia than previously thought, with odds ratios above 1.0 but not conclusively strong.
August 2017 in “韓方眼耳鼻咽喉皮膚科學會誌 = The journal of Korean Medicine Ophthalmology & Otolaryngology & Dermatology” This study examined the relationship between early-onset androgenetic alopecia and metabolic syndrome, but the abstract does not report specific findings.
April 2021 in “Research Square (Research Square)” This case report describes significant improvements in both trichotillomania and bulimia symptoms with N-acetylcysteine treatment, suggesting a potential shared pathophysiological mechanism between the disorders.
2 citations
,
June 1983 in “Proc., Annu. Meet., Air Pollut. Control Assoc.; (United States)” This case study reports that ingestion of topical minoxidil, used for hair loss, can cause severe circulatory shock and acute pulmonary edema, necessitating immediate medical intervention with fluids and vasopressors.
May 2019 in “Small Animal Dermatology” In this chapter, a 7-year-old cat's hair loss was explored, with flea bite hypersensitivity considered the most likely cause, but other reasons for excessive grooming could not be ruled out; effective ongoing flea control was suggested as a practical approach leading to a good prognosis.
1 citations
,
April 2022 in “Rheumatology” This case study describes a 4-year-old boy with juvenile dermatomyositis whose severe subcutaneous edema resisted conventional treatment, necessitating aggressive immunosuppression for disease control.
November 2025 in “Journal of Diabetes Investigation” In this case study, a man with Werner syndrome and diabetes saw improved glycemic control and insulin resistance with dapagliflozin, suggesting its potential usefulness for managing diabetes in similar patients.
11 citations
,
January 2013 in “Indian Journal of Endocrinology and Metabolism” This study concluded that mucocutaneous symptoms can assist in diagnosing diabetes mellitus and its complications, highlighting the potential for dermatologists to detect related systemic issues early in patients.
8 citations
,
May 1991 in “PubMed” This case study from Boston University details a 35-year-old woman diagnosed with congenital adrenal hyperplasia, treated with dexamethasone, leading to normalized androgen levels and successful conception.
7 citations
,
May 2014 in “Iranian Red Crescent medical journal” This case study describes a 17-year-old female with severe hirsutism diagnosed with PCOS, NC-CAH, and HAIR-AN syndrome who was successfully treated based on her specific underlying conditions.
July 2023 in “JCEM Case Reports” This case study describes a 36-year-old woman with a history of recurrent limb weakness linked to hypokalemia and later diagnosed with Cushing syndrome indicated by elevated cortisol levels and a pituitary mass, which was treated with surgery and radiosurgery.
April 2019 in “Journal of the Endocrine Society” This case study reported that even with improved adrenal androgens and testosterone levels, treating women with AH-PCOS with glucocorticoids did not significantly improve ovulatory function or hirsutism.
August 2025 in “Journal of Pediatric Endocrinology and Metabolism” This case report from a German study detailed a 2-year-old girl with virilization and precocious puberty due to a rare ovarian steroid cell tumor, finding that post-surgery, her elevated hormone levels normalized within a week, and ongoing follow-up showed no need for chemotherapy.
1 citations
,
December 2019 in “Canadian journal of ophthalmology” This study presents a case of a pubertal girl with type 1 diabetes who developed proliferative diabetic retinopathy shortly after diagnosis, suggesting the need for earlier screening in high-risk groups.
1 citations
,
October 2023 in “European Journal of Dermatology” This study found that combining hair transplantation with platelet-rich plasma injections was more effective than hair transplantation alone for improving hair loss in patients with androgenic alopecia.
5 citations
,
November 2024 in “Journal of Clinical Immunology” This study reports that a 9-week-old infant with Netherton syndrome showed rapid and sustained symptom improvement, including skin microbiome normalization and developmental progress, after off-label dupilumab treatment, without adverse reactions.
5 citations
,
July 2019 in “Applied statistics/Journal of the Royal Statistical Society. Series C, Applied statistics” In this study, applying case-only trees and random forests to a prostate cancer prevention trial revealed genotypes that may influence the efficacy of finasteride for prostate cancer prevention.
June 2026 in “UNC Libraries” This case study reported a 49-year-old woman with metastatic adrenocortical carcinoma who experienced an abscopal effect after pulse electric field ablation, leading to the resolution of three untreated liver lesions, suggesting potential benefits of this treatment combined with immunotherapy.
June 2026 in “Case Reports in Dermatology” This case study reported that in a 67-year-old woman with Netherton syndrome, treatment with dupilumab improved skin inflammation and pruritus and was associated with significant improvements in hair growth and structure, including the resolution of "bamboo" hair.
October 2024 in “Frontiers in Oncology” This case study reports a novel mutation in the TRPV3 gene causing atypical Olmsted syndrome, characterized by disabling keratoderma and squamous cell carcinoma, highlighting the need for careful long-term monitoring in affected patients.
20 citations
,
December 2020 in “Frontiers in Immunology” This study found that certain T cell-associated genes were upregulated in dogs with Vogt-Koyanagi-Harada syndrome and vitiligo, suggesting a shared immunopathogenesis with humans.
15 citations
,
January 2019 in “Journal of the Formosan Medical Association” This case study reports that adding adalimumab to a 12-year-old VKH patient's treatment allowed for ocular inflammation remission, vision improvement, and corticosteroid tapering, suggesting escalation of immunosuppression may be critical in pediatric VKH cases.
January 2025 in “Indian Dermatology Online Journal” This case study highlights the importance of a multidisciplinary approach in diagnosing and managing Vogt-Koyanagi-Harada syndrome, particularly emphasizing the role dermatologists can play in identifying early signs such as hair loss.
April 2023 in “Revista colombiana de reumatología” In this study, a 24-year-old patient with severe alopecia areata showed an excellent clinical response to the JAK inhibitor tofacitinib after one month, following unsuccessful previous treatments.